Life Sciences Tools & Services | Separation Agreements | Business Contracts

Transition and Separation Agreement by and between the Company and Ross Taylor, dated as of February 3, 2023 (CODEXIS INC, Filed With SEC on February 27, 2023)

Separation Agreement, dated as of December 20, 2022, by and between NeoGenomics, Inc. and William Bonello (NEOGENOMICS INC, Filed With SEC on February 24, 2023)

Separation Agreement and Release between the Company and Mr. Rossi dated January 18, 2023 (HARVARD BIOSCIENCE INC, Filed With SEC on January 19, 2023)

Separation Agreement and General Release of Claims between Jason Meggs and Syneos Health, Inc., dated January 5, 2023 (Syneos Health, Filed With SEC on January 9, 2023)

Separation Agreement, dated December 14, 2022, between the Company and John West (Personalis, Inc., Filed With SEC on December 14, 2022)

Separation Agreement, dated as of August 24, 2022, between Rapid Micro Biosystems, Inc. and Richard Keys (RAPID MICRO BIOSYSTEMS, INC., Filed With SEC on November 10, 2022)

Separation Agreement by and between the Company and Matthew Weinstock dated September 30, 2022 (AbSci Corp, Filed With SEC on November 9, 2022)

Separation Agreement and General Release of Claims between Syneos Health, Inc. and Paul Colvin (Syneos Health, Filed With SEC on November 4, 2022)

Transition and Separation Agreement by and between (CODEXIS INC, Filed With SEC on November 4, 2022)

Separation Agreement made as of August 31, 2022 between Terry Hammons and Sotera Health Company (Sotera Health Co, Filed With SEC on November 2, 2022)

Separation Agreement by and between the Company and E. Kevin Hrusovsky, effective as of August 8, 2022 (Quanterix Corp, Filed With SEC on August 8, 2022)

Separation Agreement and Release between AbCellera Biologics Inc. and Neil Berkley (AbCellera Biologics Inc., Filed With SEC on July 19, 2022)

Separation Agreement and Release between the Registrant and Jennifer McNealey, dated June 22, 2022 (Codex DNA, Inc., Filed With SEC on June 24, 2022)

Separation Agreement, dated as of June 10, 2022, by and between Quantum-Si Incorporated and Matthew Dyer, Ph.D (HighCape Capital Acquisition Corp., Filed With SEC on June 10, 2022)

Transition and Separation Agreement, effective July 8, 2021, between Lisa Harrington and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on May 12, 2022)

Transition and Separation Agreement by and between Berkeley Lights, Inc. and Kurt Wood (Berkeley Lights, Inc., Filed With SEC on May 9, 2022)

Separation Agreement, dated as of March 28, 2022, by and between NeoGenomics, Inc. and Mark Mallon (NEOGENOMICS INC, Filed With SEC on March 28, 2022)

Transition and Separation Agreement by and between Berkeley Lights, Inc. and Eric Hobbs (Berkeley Lights, Inc., Filed With SEC on March 2, 2022)

Transition and Separation Agreement between Bradford J. Crutchfield and 10x Genomics., Inc. dated February 17, 2022 (10x Genomics, Inc., Filed With SEC on February 18, 2022)

Separation Agreement, dated as of February 11, 2022, by and between Quantum-Si Incorporated and John Stark (HighCape Capital Acquisition Corp., Filed With SEC on February 14, 2022)

Separation Agreement and Release between Harvard Bioscience, Inc. and Ken Olson, dated as of January 26, 2022 (HARVARD BIOSCIENCE INC, Filed With SEC on January 28, 2022)

Separation Agreement, dated November 11, 2021, by and between the Company and William Geist (Quanterix Corp, Filed With SEC on November 12, 2021)

Separation and General Release Agreement (Codex DNA, Inc., Filed With SEC on November 10, 2021)

Separation Agreement, by and between Berkeley Lights, Inc. and Shaun Holt (Berkeley Lights, Inc., Filed With SEC on March 12, 2021)

Separation Agreement, dated June 12, 2020, between Bioanalytical Systems, Inc. and Daniel Thomas Oakley (BIOANALYTICAL SYSTEMS INC, Filed With SEC on August 14, 2020)

Chief Executive Officer Transition and Separation Agreement (Waters Corporation, Filed With SEC on July 29, 2020)

Separation Agreement between Garret Hampton and Ilumina dated as of November 25, 2019 (Illumina Inc, Filed With SEC on February 11, 2020)

SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS (NEOGENOMICS INC, Filed With SEC on August 8, 2019)

Separation and Release Agreement between Harvard Bioscience, Inc. and Jeffrey Duchemin (HARVARD BIOSCIENCE INC, Filed With SEC on July 8, 2019)

Separation of Employment Agreement, dated March 13, 2019, between the Company and Robert Weiskopf (ARQULE INC, Filed With SEC on May 1, 2019)

Separation and Release Agreement, dated as of November 20, 2018, by and between Troy Rhonemus and ChromaDex, Inc (ChromaDex Corp., Filed With SEC on March 7, 2019)

Separation Agreement by and between Michael Aldridge and the Company, dated August 17, 2018 (CODEXIS INC, Filed With SEC on March 1, 2019)

Life Sciences Tools & Services (32) | Separation Agreements (32)